Colony Bankcorp (CBAN) Q3 2026 Earnings Call Transcript

Colony Bankcorp reported Q3 2026 operating net income of $11.6 million and a 3.59% net interest margin, up 7 bps from Q2; operating ROA rose to 1.26%, above its 1.25% objective. The bank expects roughly 5% loan growth next year and anticipates a temporary 10–15 bps ROA pullback during First Reliance integration, with merger-related savings beginning in Q3 2027. It plans to sell about $100 million of securities yielding approximately 2% and redeploy proceeds at an assumed 5.5%, while a $19.9 million branch sale-leaseback is expected to generate a roughly $15 million pretax gain; a $16 million commercial construction relationship drove higher criticized and classified loans, which management said was collateralized and isolated.

Analysis

CBAN’s earnings setup is a timing and execution trade, not yet a clean growth story. Asset repricing and redeployment from low-yield securities can lift core spread income, but the advertised reinvestment yield is an assumption: slower loan deployment, weaker loan demand, or price competition would defer the benefit while deposit costs remain exposed to competition. Falling market rates would also reduce the yield available on new loans, though they could ease deposit pressure.

The First Reliance combination adds South Carolina scale and potential funding and fee opportunities, but two core systems create a near-term earnings drag until conversion and savings begin. The market may focus on closing and headline purchase accretion before evidence of deposit retention, cost takeout, and operating execution arrives. The sale-leaseback/securities actions should be judged on recurring earnings and liquidity—not the one-time gain: rent is a durable expense, and selling securities crystallizes losses even if the reported gain offsets them.

Credit is the key asymmetric risk: the construction exposure is described as isolated and collateralized, but appraisal value and resolution timing matter more than management’s characterization. SBSL’s stronger activity may support future fee income, yet construction-heavy production creates timing and credit sensitivity; mortgage weakness could offset some fee momentum. Near term, expect integration costs and uneven loan growth; over 6–18 months, the thesis depends on repricing and post-conversion savings. No valuation or market-price context is supplied, so conviction on upside is limited.

Key Decisions for Investors

• No immediate outright long recommendation without valuation and price context. Keep CBAN on a post-close watchlist; consider a starter position only after legal close if deposit retention and combined credit metrics remain stable.
• Track the next 1–3 quarters for core NIM excluding purchase-accounting accretion, loan deployment from the securities sale, deposit cost trajectory, and combined-company expenses. Treat failure to convert liquidity into loans near management’s stated yield assumptions as a thesis warning.
• Revisit the earnings thesis after the planned systems conversion and first evidence of cost savings. Falsifiers include a sustained rise in deposit costs that overwhelms asset repricing, credit migration beyond the construction relationship, or a material delay in integration savings.
• Do not underwrite the one-time branch-sale gain as recurring EPS or capital generation. Verify the realized securities loss, rent burden, AOCI/regulatory-capital treatment, and actual use of proceeds in filings.